J Korean Neurol Assoc.  2005 Dec;23(6):745-751.

Clinical Outcome of Balloon Angioplasty for Symptomatic Middle Cerebral Artery Stenosis

Affiliations
  • 1Department of Neurology, Chonnam National Universtiy Medical School, Gwangju, Korea. kcho@chonnam.ac.kr
  • 2Department of Radiology, Chonnam National Universtiy Medical School, Gwangju, Korea.

Abstract

BACKGROUND
The conventional management of the symptomatic stenosis of intracranial artery is the administration of antithrombotic agents while controlling the vascular risk factors. Despite medical therapy, the stroke risk for patients with intracranial artery stenosis remains high. Recently, balloon angioplasty with or without stent placement has emerged as a potential therapeutic option. This study was aimed to assess the efficacy, safety and clinical outcome of balloon angioplasty without stent placement for patients with symptomatic middle cerebral artery (MCA) stenosis. METHODS: Between February 1996 and December 2004, 41 cases (40 consecutive patients) with symptomatic MCA stenosis greater than 50% were treated with balloon angioplasty. Patient records were retrospectively reviewed for angiographic findings, periprocedural complications, and long-term outcome. RESULTS: Mean stenosis rate (75.4%) was significantly reduced after the procedure (26.6%). The procedure revealed that 4 of the 41 (9.7%) patients developed major related complications (one death and 3 minor strokes). Other minor related complications were also observed in 7 patients, which included 3 transient neurological deficits, 3 asymptomatic dissections and 1 asymptomatic petechial hemorrhage. During the follow-up period (2-108 months), none of the patients developed ischemic stroke in the territory of treated MCA, however one patient developed TIA at the 12 month after angioplasty. CONCLUSIONS: Angioplasty without stent placement is technically feasible, safe and effective in the patients with symptomatic MCA stenosis.

Keyword

Stroke; Stenosis; Middle cerebral artery; Angioplasty

MeSH Terms

Angioplasty
Angioplasty, Balloon*
Arteries
Constriction, Pathologic*
Fibrinolytic Agents
Follow-Up Studies
Hemorrhage
Humans
Middle Cerebral Artery*
Retrospective Studies
Risk Factors
Stents
Stroke
Fibrinolytic Agents
Full Text Links
  • JKNA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr